Literature DB >> 27859638

Alterations of the circadian system in Parkinson's disease patients.

Karim Fifel1.   

Abstract

Alterations of circadian rhythms are among the most debilitating non-motor symptoms in Parkinson's Disease (PD). Although a growing awareness towards these symptoms has occurred during the last decade, their underlying neuropathophysiology remains poorly understood and consequently no effective therapeutic strategies are available to alleviate these problems. Recent studies have investigated multiple circadian rhythms at different stages of PD. The advances made have allowed an accurate evaluation of the affected underlying pathways and mechanisms. Here I dissect, over disease progression, the relative causal contribution to health impairments in PD patients of dysfunctions in the different components of the neural network governing circadian rhythms. A deeper understanding of these mechanisms will provide not only a greater understanding of disease neuropathology, but also hold the promise for effective therapies.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; SCN; circadian

Mesh:

Year:  2016        PMID: 27859638     DOI: 10.1002/mds.26865

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

Review 1.  Chronotherapies for Parkinson's disease.

Authors:  Karim Fifel; Aleksandar Videnovic
Journal:  Prog Neurobiol       Date:  2019-01-15       Impact factor: 11.685

Review 2.  Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.

Authors:  Michele Goulart Dos Santos; Lucia Emanueli Schimith; Corinne André-Miral; Ana Luiza Muccillo-Baisch; Bruno Dutra Arbo; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

3.  The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.

Authors:  Liang Kou; Xiaosa Chi; Yadi Sun; Chao Han; Fang Wan; Junjie Hu; Sijia Yin; Jiawei Wu; Yunna Li; Qiulu Zhou; Wenkai Zou; Nian Xiong; Jinsha Huang; Yun Xia; Tao Wang
Journal:  J Neuroinflammation       Date:  2022-06-06       Impact factor: 9.587

Review 4.  Light Therapy in Parkinson's Disease: Towards Mechanism-Based Protocols.

Authors:  Karim Fifel; Aleksandar Videnovic
Journal:  Trends Neurosci       Date:  2018-03-24       Impact factor: 13.837

Review 5.  Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond.

Authors:  Chiara La Morgia; Fred N Ross-Cisneros; Alfredo A Sadun; Valerio Carelli
Journal:  Front Neurol       Date:  2017-05-04       Impact factor: 4.003

6.  Disruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1-BMAL1 Pathway in 6-OHDA-Induced Models of Parkinson's Disease.

Authors:  Yali Wang; Dongjun Lv; Wenwen Liu; Siyue Li; Jing Chen; Yun Shen; Fen Wang; Li-Fang Hu; Chun-Feng Liu
Journal:  Oxid Med Cell Longev       Date:  2018-04-18       Impact factor: 6.543

7.  Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson's Disease: A Cross-Sectional Study.

Authors:  Linyi Li; Zhenxiang Zhao; Jianjun Ma; Jinhua Zheng; Shen Huang; Shiyu Hu; Qi Gu; Siyuan Chen
Journal:  Front Neurosci       Date:  2020-05-19       Impact factor: 4.677

Review 8.  Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review.

Authors:  Douglas M Wallace; William K Wohlgemuth; Lynn Marie Trotti; Amy W Amara; Irene A Malaty; Stewart A Factor; Sagarika Nallu; Lara Wittine; Robert A Hauser
Journal:  Mov Disord Clin Pract       Date:  2020-02-03

9.  Investigation on sleep and mental health of patients with Parkinson's disease during the Coronavirus disease 2019 pandemic.

Authors:  Yun Xia; Liang Kou; Guoxin Zhang; Chao Han; Junjie Hu; Fang Wan; Sijia Yin; Yadi Sun; Jiawei Wu; Yunna Li; Zhentao Zhang; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Sleep Med       Date:  2020-09-10       Impact factor: 3.492

10.  Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease.

Authors:  Isabel Ortuño-Lizarán; Gema Esquiva; Thomas G Beach; Geidy E Serrano; Charles H Adler; Pedro Lax; Nicolás Cuenca
Journal:  Acta Neuropathol Commun       Date:  2018-09-10       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.